About Aeternitas Pharmaceuticals Private Limited
Data last updated:
Aeternitas Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Trisun Holdings Private Limited. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 29 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2018PTC127249. Its GSTIN is 36AAGCT9494G1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sarada Lakshmi Gudipati and Dronamraju Prabhu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D. No. 265D Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.38 Lakh, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹4.35 Lakh (net margin -80.9%) and EBITDA of -₹51,105 (EBITDA margin -9.5%). Revenue has declined at a compounded annual rate (CAGR) of 70% over three years and 22% over five years.
For more details, the company can be reached via its website trisunpharma.com.
Company details
Contact details
Aeternitas Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is trisunpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD. No. 265D Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
To see the full contact details of Aeternitas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aeternitas Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aeternitas Pharmaceuticals Private Limited, buy the company report.
Financials of Aeternitas Pharmaceuticals Private Limited
FY 2025 filings availableAeternitas Pharmaceuticals Private Limited reported revenue of ₹5.38 Lakh (down 71% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 71% fall in the latest year. EBITDA rose 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹51,105 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.5% | ||||
| Net Profit Margin | -80.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aeternitas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aeternitas Pharmaceuticals Private Limited
Aeternitas Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarada Lakshmi Gudipati | Director | 30 Jan 2020 | 6 Years 9 Months | Current |
| Dronamraju Prabhu Also directs: Omniceutics Healthcare Private Limited, Trisun Innovations Private Limited, Thunderbolt Foods Private Limited and 1 more | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Aeternitas Pharmaceuticals Private Limited is audited by C V RAMANA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C V RAMANA & ASSOCIATES | FY 2021 | 009188S |
Shareholding
The shareholding of Aeternitas Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public |
To see the full shareholding pattern of Aeternitas Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aeternitas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aeternitas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aeternitas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCT9494G1ZQ | Telangana | Active | 14 Dec 2018 |
To see the full GST registrations and return filing status of Aeternitas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aeternitas Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Krishna Vikas Peddibhotla ceased to be Director on 30 Jan 2020.
Frequently asked questions
Aeternitas Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 29 September 2018 (8+ years old) and is registered under CIN U24100TG2018PTC127249.
Aeternitas Pharmaceuticals has 2 current directors:
- Sarada Lakshmi Gudipati - Director
- Dronamraju Prabhu - Director
The latest financial statements of Aeternitas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Aeternitas Pharmaceuticals is 36AAGCT9494G1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Aeternitas Pharmaceuticals is U24100TG2018PTC127249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aeternitas Pharmaceuticals was incorporated on 29 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Krishna Vikas Peddibhotla ceased to be Director on 30 Jan 2020. Nukala Sitaramam ceased to be Director on 30 Jan 2020. Sarada Lakshmi Gudipati was appointed as Director on 30 Jan 2020. Aeternitas Pharmaceuticals has 4 board changes on record in total.
Aeternitas Pharmaceuticals can be reached through the website trisunpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Aeternitas Pharmaceuticals is at D. No. 265D Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033.
Aeternitas Pharmaceuticals operates in the consumer goods industry, in the health and beauty retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
